Key Highlights

● An Aug. 20, 2026 Form 8-K disclosed a Nasdaq notice on minimum stockholders' equity.

● Stockholders' Equity swung from $42.5 million to negative $19.7 million by June 30.

● The Warrant Liability rose to about $124.4 million, producing a roughly $80.9 million non-cash loss.

● Shares closed at $1.89 on Nov. 13.

T3 Defense Inc. (NASDAQ:DFNS), the defense technology Holding Company formerly known as Nukkleus, has spent recent weeks announcing orders, acquisitions and product launches. Behind those headlines sits a balance-sheet issue that could matter just as much for shareholders: a Nasdaq notice that the company no longer meets the $10 million minimum stockholders' equity standard for its Global Market listing. With shares closing at $1.89 on Nov. 13, according to market data, the path back to compliance is a central question for the small-cap name.

Latest Company Context

According to an Aug. 20, 2026 Form 8-K, Nasdaq's Listing Qualifications Department notified T3 Defense that it did not satisfy Listing Rule 5450(b)(1)(A), nor the alternative market-value or net-income standards. Stockholders' equity swung from $42.5 million at March 31, 2026 to negative $19.7 million at June 30. Management attributed the decline to warrants issued in a $10 million February 2026 private placement, whose entire proceeds were allocated to a common warrant liability. The Fair Value of that liability rose from about $25.4 million at initial recognition to about $124.4 million at June 30, producing a roughly $80.9 million non-cash loss in the second quarter alone. The company had until Oct. 5, 2026 to submit a compliance plan; if accepted, Nasdaq staff may grant up to 180 calendar days from the notice date. The outcome of that plan was not disclosed.

Key Business and index Drivers

The equity shortfall is largely an accounting consequence rather than a cash drain, which makes the warrant liability itself the key variable. Because the liability is marked to fair value, its size can shift with the share price; a lower stock price may reduce it, while exercises or restructuring of the warrants could change the picture more decisively. Operationally, the company has been building Revenue sources.

Subsidiary Positech began deliveries on a $3.9 million defense order in October, with remaining deliveries expected in the first quarter of 2027, and unit Rimon won a roughly $1.3 million power-generation order for European air-defense production. In late October T3 agreed to acquire KeepZone AI for $1.0 million in initial stock plus a capped earn-out of up to $5.0 million, and in November it announced exclusive Israeli distribution rights for Copting GmbH's tethered drone system. Equity issued for acquisitions could also count toward rebuilding stockholders' equity.

What Investors Should Watch

Several items could clarify the compliance path. Investors may look for any disclosure on whether Nasdaq accepted the plan submitted by the Oct. 5 deadline; a full 180-day extension from the Aug. 20 notice would run to roughly mid-February 2027. The next Quarterly Report should show where stockholders' equity and the warrant liability stood at Sept. 30. Closing of the KeepZone AI deal, expected within 60 days of its Oct. 27 signing and subject to conditions including Nasdaq notification, is another near-term marker. Subsidiary Tiltan's product showcase at I/ITSEC in Orlando from Nov. 30 to Dec. 3 may indicate commercial traction in U.S. Training markets, though the company has cautioned there is no assurance of orders. Any new financing, warrant amendment or reverse split proposal would also bear directly on dilution and listing status.

Defense Orders Against a Distorted Balance Sheet

T3 Defense combines a growing list of defense orders and bolt-on acquisitions with a Balance Sheet distorted by a large warrant liability that has pushed reported equity below Nasdaq's threshold. If Nasdaq does not accept the company's plan, or compliance is not shown within any extension, the listing could face a delisting determination, which the company could appeal. How the company resolves that gap, and at what cost to existing holders, may shape sentiment as much as the operating news flow does.